Related Experiment Video
Updated: Dec 8, 2025

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
Keith A Lawson1,2,3, Cristovão M Sousa4, Xiaoyu Zhang1,2
1Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Abstract:
The genetic circuits that allow cancer cells to evade destruction by the host immune system remain poorly understood1-3. Here, to identify a phenotypically robust core set of genes and pathways that enable cancer cells to evade killing mediated by cytotoxic T lymphocytes (CTLs), we performed genome-wide CRISPR screens across a panel of genetically diverse mouse cancer cell lines that were cultured in the presence of CTLs. We identify a core set of 182 genes across these mouse cancer models, the individual perturbation of which increases either the sensitivity or the resistance of cancer cells to CTL-mediated toxicity. Systematic exploration of our dataset using genetic co-similarity reveals the hierarchical and coordinated manner in which genes and pathways act in cancer cells to orchestrate their evasion of CTLs, and shows that discrete functional modules that control the interferon response and tumour necrosis factor (TNF)-induced cytotoxicity are dominant sub-phenotypes. Our data establish a central role for genes that were previously identified as negative regulators of the type-II interferon response (for example, Ptpn2, Socs1 and Adar1) in mediating CTL evasion, and show that the lipid-droplet-related gene Fitm2 is required for maintaining cell fitness after exposure to interferon-γ (IFNγ). In addition, we identify the autophagy pathway as a conserved mediator of the evasion of CTLs by cancer cells, and show that this pathway is required to resist cytotoxicity induced by the cytokines IFNγ and TNF. Through the mapping of cytokine- and CTL-based genetic interactions, together with in vivo CRISPR screens, we show how the pleiotropic effects of autophagy control cancer-cell-intrinsic evasion of killing by CTLs and we highlight the importance of these effects within the tumour microenvironment. Collectively, these data expand our knowledge of the genetic circuits that are involved in the evasion of the immune system by cancer cells, and highlight genetic interactions that contribute to phenotypes associated with escape from killing by CTLs.
Insights
Cancer cells evade immune attack through complex genetic pathways. This study identifies 182 key genes and highlights the roles of interferon response and autophagy in immune evasion, crucial for developing new cancer immunotherapies.
Area of Science:
- Immunology
- Cancer Biology
- Genetics
Background:
- Cancer cells possess sophisticated genetic mechanisms to evade immune system detection and destruction.
- Understanding these evasion strategies is critical for advancing cancer immunotherapy.
Purpose of the Study:
- To identify a core set of genes and pathways enabling cancer cells to evade killing by cytotoxic T lymphocytes (CTLs).
- To elucidate the coordinated genetic interactions governing immune evasion in cancer.
Main Methods:
- Genome-wide CRISPR screens were conducted on diverse mouse cancer cell lines co-cultured with CTLs.
- Genetic co-similarity analysis was employed to explore gene and pathway interactions.
- In vivo CRISPR screens were integrated with cytokine and CTL genetic interaction mapping.
Main Results:
- A core set of 182 genes was identified, where perturbation altered cancer cell sensitivity or resistance to CTL-mediated killing.
- Dominant sub-phenotypes involved the interferon response and tumor necrosis factor (TNF)-induced cytotoxicity.
- The autophagy pathway was confirmed as a conserved mediator of CTL evasion, crucial for resisting IFNγ and TNF-induced cytotoxicity.
Conclusions:
- The study reveals key genetic circuits, including interferon response regulators and the autophagy pathway, that cancer cells utilize to evade CTLs.
- These findings provide a deeper understanding of cancer immune evasion mechanisms and highlight potential therapeutic targets within the tumor microenvironment.
More Related Videos
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Intrinsic Apoptotic Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers
Cancers Originate from Somatic Mutations in a Single Cell
mTOR Signaling and Cancer Progression
The mTOR pathway or the...